Discussing the latest oral solid dosage challenges and trends with John Ross, president at Metrics Contract Services & Maria Lundberg, vice president of Product Development at Recipharm.
Brain storm
Q: Can you outline the key challenges and growth opportunities that have happened in the OSD market recently?
Ross: The major challenge for the market lies in the misalignment of installed capacity compared with the contemporary needs to produce today’s OSD drug products.